Two new treatments are proving to be the most effective treatment in decades for some people with bladder cancer, according to groundbreaking trial results in two separate studies.
Researchers found that in both trials, patients who received a combination of immunotherapy drugs lived longer than those who received standard chemotherapy treatment, marking a never-before-seen improvement in treatment for advanced bladder cancer.
The advancements are seen as "monumental" in urology, Dr. Andrea Apolo of the National Cancer Institute's Genitourinary Malignancies Branch said in a press release. "The future looks bright for our patients."
Read Full Article Here